References
Miesbach W, Gilzinger A, Gokpinar B, et al.: Prevalence of antiphospholipid antibodies in patients with neurological symptoms. Clin Neurol Neurosurg 2006, 108:135–142.
Brey RL: Antiphospholipid antibodies in young adults with stroke. J Thromb Thrombolysis 2005, 20:105–112.
Jara LJ, Medina G, Vera-Lastra O, Barile L: The impact of gender on clinical manifestations of primary antiphospholipid syndrome. Lupus 2005, 14:607–612.
Roldan CA, Gelgand EA, Qualls CR, Sibbitt WL Jr.: Valvular heart disease as a cause of cerebrovascular disease in patients with systemic lupus erythematosus. Am J Cardiol 2005, 95:1441–1447.
Perez-Villa F, Font J, Azqueta M, et al.: Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study. Arthritis Rheum 2005, 53:460–467.
Terashi H, Uchiyama S, Hashimoto S, et al.: Clinical characteristics of stroke patients with antiphospholipid antibodies. Cerebrovasc Dis 2005, 19:384–390.
Chong JY, Mohr JP: Anticoagulation and platelet antiaggregation therapy in stroke prevention. Curr Opin Neurol 2005, 18:53–57.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Merrill, J.T. Antiphospholipid syndrome: What’s new in understanding antiphospholipid antibody-related stroke?. Curr Rheumatol Rep 8, 159–161 (2006). https://doi.org/10.1007/s11926-996-0019-1
Issue Date:
DOI: https://doi.org/10.1007/s11926-996-0019-1